WANBURY
Back to All Ratios
|
WANBURY Last 5 Year Current Ratio History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Current Ratio(x) | 0.38 | 0.48 | 0.27 | 0.30 | 0.27 |
What is the latest Current Ratio ratio of WANBURY ?
Year | Current Ratio |
---|---|
Mar2023 | 0.38 |
Mar2022 | 0.48 |
Mar2021 | 0.27 |
Mar2020 | 0.30 |
Mar2019 | 0.27 |
How is Current Ratio of WANBURY Trending?
Years | Current Ratio | % Change | |
---|---|---|---|
Mar2023 | 0.38 | -20.83 | |
Mar2022 | 0.48 | 77.78 | |
Mar2021 | 0.27 | -10.00 | |
Mar2020 | 0.3 | 11.11 | |
Mar2019 | 0.27 | - |
Other Financial Ratios of WANBURY
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Quick Ratio Interest Cover Total Debt/Mcap |
Compare Current Ratio ratio of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹499.3 Cr | -5.7% | 7.9% | 228.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -5.7% |
7.9% |
228.5% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses